10/02/2025 10:07
New International Director Propels DLR Group into Next Era of Global Design

The global, 100% employee-owned, integrated design firm DLR Group has announced the appointment of Principal Eric Phillips, AIA, NCARB, as International Director. Phillips is a licensed architect with over 25 years of experience shaping and diversifying international and domestic design practices. In his new role, he will evolve DLR Group’s work in the Middle East and China and guide the integrated practice into new markets, from Canada and Europe to Asia and throughout the Pacific Rim. This p...

10/02/2025 10:00
payabl. Joins EPI as a Licensed Member to Enable Wero Payments in Europe

Leading financial technology provider payabl. has today announced that it has become one of the first licensed members of the European Payments Initiative (EPI) and a direct participant in Wero, EPI’s newly launched pan-European, fast and secure digital wallet, already used by more than 43.5 million Europeans. By integrating as a direct acquirer, payabl. enables merchants, as well as other payment service providers (PSPs), across Europe to offer instant, secure account-to-account (A2A) paymen...

10/02/2025 10:00
Are you looking for funding for your performing arts project? We are announcing Ibsen Scope Grants 2026.

The Ibsen Scope Grants program offers funding for innovative performing arts projects and is now applicable for individual artists, theatre companies, institutions, and organizations worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002841977/en/Instinto, Ibsen Scope Grant winner 2022 from Brazil. Photo by Vilmar Carvalho. The program amounts to a total of NOK 2.000.000,-. (Approx. Euro 180.000,- /USD 190.000,-). The pr...

10/02/2025 12:00
Raxio-Laser Light Team to Transform Digital Access in Markets Home to Half a Billion People

Africa’s fastest-growing but least-served online markets are set to gain more affordable, reliable, and higher-speed internet access through a partnership between Raxio Group, the continent’s most expansive data centre operator, and Laser Light Africa, the regional unit of the U.S.-based operator of one of the world’s most advanced integrated digital networks. The landmark agreement pairs Raxio’s expanding network of world-class Tier III carrier-neutral data centres with Laser Light’s scale a...

10/02/2025 12:00
Aprovall and Owlin Join Forces to Deliver Real-Time Third-Party Risk Insights to 32,000 Users

This partnership brings together Aprovall’s 20 years of expertise in third-party risk assessment and management with Owlin’s global adverse media monitoring solution for evaluating and monitoring external third-party risk. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002377785/en/Owlin and Aprovall announce strategic partnership By joining forces, Aprovall’s TPRM platform now incorporates Owlin’s intelligence, enabling its 32,0...

10/02/2025 12:00
Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it has begun opening clinical trial sites in the European Union (EU) and may begin screening participants for the Phase 3 ALPHA-ORBIT trial of navenibart, an investigational monoclonal antibody inhibitor of plasma kallikrein in development for the treatment of hereditary angioedema (HAE) with the potential for dosing every...

10/02/2025 13:01
Carta Acquires Accelex to Deliver AI-Powered Data Automation and Transparency for Capital Allocators

Carta, the software platform purpose-built for private capital, today announced it has acquired Accelex, the AI-powered data automation platform focused on alternative investments for institutional limited partners (LPs). The acquisition deepens Carta’s commitment to serving its network of more than 125,000 Limited Partners by offering unprecedented clarity into the drivers of alternative asset portfolio performance. With our new LP Portfolio Analytics suite powered by Accelex, Carta will enabl...

10/02/2025 13:03
PPG announces Secret Safari as 2026 Color of the Year

PPG (NYSE: PPG) today announced Secret Safari (PPG1110-4) as its 2026 Color of the Year. A versatile yellow-green, Secret Safari balances soothing comfort with a touch of energy and vitality, making it suitable for a wide range of applications. The shade is part of PPG’s 2026 global color theme, Parallels, which includes three distinct palettes: Authentic, Visionary and Expressive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202510...

10/02/2025 13:00
Hyperice Introduces Virgil van Dijk as Athlete Ambassador

Hyperice, the global leader in high-performance wellness technology, today announced Dutch international and Liverpool FC Defender and Captain Virgil van Dijk as its newest athlete ambassador. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002549534/en/As a regular user of Hyperice products - having used Normatec for his post-match recovery for years - van Dijk has partnered with the brand to highlight the importance of recovery ...

10/02/2025 13:00
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair

Neuraptive Therapeutics, Inc., a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI), today announced the first patient has been enrolled in its phase 3 clinical trial using NTX-001 in peripheral nerve injuries due to trauma. The phase 3 study is a multicenter, randomized, subject and evaluator blinded, controlled study evaluating the safety and efficacy of NTX-001 compared to standard of care (neurorrhaphy) in the treatment of up...